Free Trial

Jaguar Health (JAGX) Competitors

Jaguar Health logo
$4.51 -0.04 (-0.88%)
As of 10:07 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

JAGX vs. IXHL, SPRB, NERV, BCDA, FLGC, ORGS, IPA, LPTX, AFMD, and BGXX

Should you be buying Jaguar Health stock or one of its competitors? The main competitors of Jaguar Health include Incannex Healthcare (IXHL), Spruce Biosciences (SPRB), Minerva Neurosciences (NERV), BioCardia (BCDA), Flora Growth (FLGC), Orgenesis (ORGS), ImmunoPrecise Antibodies (IPA), Leap Therapeutics (LPTX), Affimed (AFMD), and Bright Green (BGXX). These companies are all part of the "pharmaceutical products" industry.

Jaguar Health vs.

Incannex Healthcare (NASDAQ:IXHL) and Jaguar Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations, dividends and community ranking.

Jaguar Health received 1835 more outperform votes than Incannex Healthcare when rated by MarketBeat users.

CompanyUnderperformOutperform
Incannex HealthcareN/AN/A
Jaguar HealthOutperform Votes
1835
88.65%
Underperform Votes
235
11.35%

Incannex Healthcare has a net margin of 0.00% compared to Jaguar Health's net margin of -360.13%. Incannex Healthcare's return on equity of -289.30% beat Jaguar Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Incannex HealthcareN/A -289.30% -154.96%
Jaguar Health -360.13%-326.62%-67.02%

0.4% of Incannex Healthcare shares are owned by institutional investors. Comparatively, 12.0% of Jaguar Health shares are owned by institutional investors. 26.5% of Incannex Healthcare shares are owned by company insiders. Comparatively, 0.4% of Jaguar Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Jaguar Health had 4 more articles in the media than Incannex Healthcare. MarketBeat recorded 5 mentions for Jaguar Health and 1 mentions for Incannex Healthcare. Jaguar Health's average media sentiment score of 0.38 beat Incannex Healthcare's score of 0.00 indicating that Jaguar Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Incannex Healthcare
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Jaguar Health
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Incannex Healthcare has higher earnings, but lower revenue than Jaguar Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Incannex Healthcare$98K118.28-$18.46M-$1.39-0.47
Jaguar Health$10.48M0.28-$41.30MN/AN/A

Incannex Healthcare has a beta of 7.49, suggesting that its share price is 649% more volatile than the S&P 500. Comparatively, Jaguar Health has a beta of 1.11, suggesting that its share price is 11% more volatile than the S&P 500.

Summary

Incannex Healthcare and Jaguar Health tied by winning 6 of the 12 factors compared between the two stocks.

Remove Ads
Get Jaguar Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JAGX vs. The Competition

MetricJaguar HealthPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$2.95M$6.56B$5.40B$7.28B
Dividend YieldN/A2.85%4.87%4.05%
P/E RatioN/A6.8522.8817.61
Price / Sales0.28194.91357.3086.64
Price / CashN/A65.6738.1634.64
Price / Book1.125.746.323.86
Net Income-$41.30M$142.37M$3.21B$247.18M
7 Day Performance-9.80%-9.71%-6.89%-6.27%
1 Month Performance-68.35%-12.66%-1.87%-8.87%
1 Year Performance-96.12%-16.65%4.62%-6.18%

Jaguar Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JAGX
Jaguar Health
0.5826 of 5 stars
$4.51
-0.9%
N/A-95.9%$2.95M$10.48M0.0050Upcoming Earnings
IXHL
Incannex Healthcare
0.3403 of 5 stars
$0.68
-3.4%
N/A-81.0%$12.08M$98,000.00-0.493News Coverage
Gap Up
SPRB
Spruce Biosciences
2.3177 of 5 stars
$0.29
-1.7%
$2.50
+761.8%
-64.5%$11.98M$7.10M-0.3120News Coverage
Gap Down
NERV
Minerva Neurosciences
2.4114 of 5 stars
$1.70
-6.1%
$5.00
+194.1%
-39.4%$11.89MN/A-3.869Analyst Forecast
Gap Up
BCDA
BioCardia
2.707 of 5 stars
$2.54
-9.3%
$25.00
+884.3%
-64.4%$11.89M$58,000.00-0.6140Gap Up
High Trading Volume
FLGC
Flora Growth
3.298 of 5 stars
$0.61
-6.9%
$5.00
+726.4%
-80.9%$11.76M$59.51M-0.46280Gap Down
ORGS
Orgenesis
N/A$2.44
-27.6%
N/AN/A$11.71M$662,000.000.00150High Trading Volume
IPA
ImmunoPrecise Antibodies
1.8383 of 5 stars
$0.38
-4.0%
$4.00
+962.4%
-76.6%$11.70M$24.07M-0.4880Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
Gap Up
LPTX
Leap Therapeutics
2.2484 of 5 stars
$0.31
-3.6%
$4.92
+1,511.5%
-87.6%$11.69MN/A-0.1640Short Interest ↓
Gap Down
AFMD
Affimed
4.2744 of 5 stars
$0.72
-7.4%
$13.50
+1,766.7%
-90.5%$11.64M$877,000.000.00200Analyst Forecast
Short Interest ↓
News Coverage
Gap Up
BGXX
Bright Green
N/AN/AN/AN/A$11.47MN/A-1.002Gap Down
Remove Ads

Related Companies and Tools


This page (NASDAQ:JAGX) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners